Besides, KMT2C is regarded as a tumor suppressor, and deletion of this gene is correlated with unfavorable prognosis of breast cancer [48], acute myeloid leukemia [49], and gastric adenocarcinoma [50]. Here, KMT2C is linked to breast cancer.